What's new

Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 18, Status: Authorised

Apr 7, 2025 - 15:59
 0
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 18, Status: Authorised
Read More

Tags:

Previous Article

J&J's Shockwave Medical to study Javelin lithotripsy in coronary arteries

Next Article

Parisian department store BHV appoints new CEO

Related Posts

Human medicines European public assessment report (EPAR): Kisunla, donanemab, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

Herbal medicinal product: Salicis cortex, Salix [various species including S. purpurea L.; S. daphnoides Vill.; S. fragilis L.], F: Assessment finalised

Herbal medicinal product: Salicis cortex, Salix [variou...

Apr 1, 2025  0

2024-2026 Work Plan of the Good Clinical Practice Inspe...

Mar 17, 2025  0